Patients with symptomatic (New York Heart Association [NYHA] class III or IV) systolic (left ventricular ejection fraction [LVEF] ≤40%) congestive heart failure (CHF) were randomized to ...
Aims In the Digitalis Investigation Group (DIG) trial, digoxin reduced mortality or hospitalization due to heart failure ... HF patients with NYHA class III–IV, LVEF <25%, or CTR >55%, and ...
Factors portending the greatest risk for cardiovascular death in control patients were inflammation (baseline plasma high-sensitivity C-reactive protein ≥2 mg/L; p=0.003) and ischemic HFrEF etiology ...
CHICAGO, IL—A novel noninvasive intracardiac pressure monitoring device powered by artificial intelligence (AI) could be a potential alternative to invasive monitoring in patients with heart failure ...